Min Xia
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 2
- Oncology 8
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Chris Saris (2 shared papers)Mohd Azam (1 shared paper)Frederick W. Quelle (1 shared paper)Paul Tempst (1 shared paper)Hediye Erdjument‐Bromage (1 shared paper)Roshni Basu (1 shared paper)James N. Ihle (1 shared paper)Christian Schindler (1 shared paper)
- Journals
- Blood (5 papers)International Journal of Technology Management (2 papers)iScience (1 paper)Medicine (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Min Xia
26 papers receiving 702 citations
Peers
Comparison fields: 5 of 68
- Hematology 179
- Genetics 126
- Oncology 315
- Immunology 239
- Cancer Research 121
Countries citing papers authored by Min Xia
This map shows the geographic impact of Min Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xia more than expected).
Fields of papers citing papers by Min Xia
This network shows the impact of papers produced by Min Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xia. The network helps show where Min Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 304 | |
| 2 | 1995 | 126 | |
| 3 | 1995 | 58 | |
| 4 | 2018 | 46 | |
| 5 | 2006 | 37 | |
| 6 | 2021 | 26 | |
| 7 | 1990 | 20 | |
| 8 | 2015 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2024 | 11 | |
| 11 | 2018 | 11 | |
| 12 | 2025 | 6 | |
| 13 | 2020 | 6 | |
| 14 | [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease]. | 2006 | 6 |
| 15 | [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease]. | 2006 | 6 |
| 16 | 2024 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2022 | 3 |
About Min Xia
Min Xia is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Hematology, having authored 30 papers that have together received 714 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers), Economic Development and Digital Transformation (2 papers), Cancer-related Molecular Pathways (2 papers), Immune Cell Function and Interaction (2 papers), Platelet Disorders and Treatments (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Hematology (179 citations), Genetics (126 citations), Oncology (315 citations), Immunology (239 citations) and Cancer Research (121 citations). Min Xia has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Chris Saris, Mohd Azam, Frederick W. Quelle, Paul Tempst, Hediye Erdjument‐Bromage, Roshni Basu, James N. Ihle, Christian Schindler, David J. Hill and Frederick A. Fletcher. Their work appears in journals such as Blood, International Journal of Technology Management, iScience, Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.